Global Alopecia Treatment

Global Alopecia Treatment

Global Alopecia Treatment

Global Alopecia Treatment (Hair Loss) Market is expected to rise from its initial estimated value of USD 8.21 billion in 2018 to an estimated value of USD 12.40 billion by 2026 registering a CAGR of 5.3% in the forecast period of 2019-2026.

This rise in the market can be attributed to the rising geriatric population along with high demand for surgical hair transplant and changing lifestyle.

This Alopecia Treatment (Hair Loss) market analysis report profiles leading companies of the market along with the emerging new ventures who are creating an impact on the global market with their latest innovations and technologies.

The study includes information on key segmentation of the global Alopecia Treatment (Hair Loss)  market on the basis of type/product, application and geography (country/region).

Each of the segments included in the report is studied in relation to different factors such as market size, market share, value, growth rate and other quantitative information.

The competitive analysis included in this Alopecia Treatment (Hair Loss) market study allows readers to understand the difference between players and how they are operating among themselves on a global scale.

Few of the major market competitors currently working in the alopecia treatment (hair loss) market are



Dr Reddy’s Laboratories Ltd.,


Merck & Co., Inc,

Ranbaxy Laboratories Ltd,

Phyto – Alès Groupe,

Kirkland Signature,



Key Developments in the Market:

In January 2018, Concert Pharmaceuticals, Inc. announced U.S. FDA granted Fast Track designation for CTP-543, a novel, oral Janus kinase (JAK) inhibitor for the treatment of moderate-to-severe alopecia areata, a disease which attacks the hair follicles, leading to hair loss.

In May 2018, Histogen, Inc (U.S.) announced that received approval to Investigational New Drug (IND) application from the US Food and Drug Administration (FDA) to study its lead product in female diffuse hair loss.

In March 2017, Perrigo Perrigo Company PLC (U.S.) announced the launch of over-the-counter Women’s Rogaine, which helps to regrow hair on top of the scalp.

Table Of Content:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Global Alopecia Treatment (Hair Loss) Market Landscape

Part 04: Global Alopecia Treatment (Hair Loss) Market Sizing

Part 05: Global Alopecia Treatment (Hair Loss) Market Segmentation By Product

Part 06: Five Forces Analysis

Part 07: Customer Landscape

Part 08: Geographic Landscape

Part 09: Decision Framework
Part 10: Drivers And Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Vendor Analysis

Global Alopecia Treatment


Recent Posts